Using the liver insulin receptor knockout (LIRKO) mouse as a model of pure hepatic insulin resistance it has been demonstrated that hepatic insulin resistance alone can produce both the dyslipidemia and increasing risk of atherosclerosis associated with the metabolic syndrome [51]. The gene discussed is INSR; the disease is metabolic syndrome.